Ronald Bronsaer active positions
| Companies | Position | Start | End |
|---|---|---|---|
CellMade SAS
 CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Chief Executive Officer | 2009-06-23 | - |
| Chairman | 2009-06-23 | - | |
| Founder | 2006-12-31 | - |
Career history of Ronald Bronsaer
Former positions of Ronald Bronsaer
| Companies | Position | Start | End |
|---|---|---|---|
| CAMBREX CORPORATION | Corporate Officer/Principal | 2006-12-31 | 2006-12-31 |
Statistics
International
| France | 2 |
| United States | 2 |
Operational
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
CellMade SAS
CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Health Technology |
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
- Stock Market
- Insiders
- Ronald Bronsaer
- Experience
